参考文献:(上下滑动可浏览)[1]Adeyemi-Fowode, O., & Stambough, K. C. (2022). General Approaches to Medical Management of Menstrual Suppression. OBSTETRICS AND GYNECOLOGY, 140(3), 528-541.
[2]Hillard, P. A. (2014). Menstrual suppression: current perspectives. International journal of women's health, 6, 631.
[3]Kaunitz, A. M. (2000). Menstruation: choosing whether… and when. Contraception, 62(6), 277-284.
[4]Jain, V., & Wotring, V. E. (2016). Medically induced amenorrhea in female astronauts. npj Microgravity, 2(1), 1-6.
[5]Polis, C. B., Hussain, R., & Berry, A. (2018). There might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes. Reproductive health, 15(1), 1-17.
[6]Mao L, Xi S, Bai W, Yao C, Zhou Y, Chen X, Sun Y. Menstrual patterns and disorders among Chinese women of reproductive age: A cross-sectional study based on mobile application data. Medicine (Baltimore). 2021 Apr 23;100(16):e25329.
[7]Mao L, Bai W, Huo Y, et al. Cross-sectional study of contraceptive use among Chinese women of reproductive age: results based on a mobile application (APP)-derived data. Arch Gynecol Obstet. 2018;297(5):1193-1199.
[8]Teichmann A, Apter D, Emerich J, et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception. 2009;80(6):504-511. doi:10.1016/j.contraception.2009.05.128
[9]复方口服避孕药临床应用中国专家共识专家组.(2015).复方口服避孕药临床应用中国专家共识. 中华妇产科杂志(02),81-91.